These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 19742193)

  • 1. Neurobiology of Alzheimer's disease.
    Mohandas E; Rajmohan V; Raghunath B
    Indian J Psychiatry; 2009 Jan; 51(1):55-61. PubMed ID: 19742193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiological pathways to Alzheimer's disease: Amyloid-beta, TAU protein or both?
    de Paula VJR; Guimarães FM; Diniz BS; Forlenza OV
    Dement Neuropsychol; 2009; 3(3):188-194. PubMed ID: 29213627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.
    Ferrer I; Gomez-Isla T; Puig B; Freixes M; Ribé E; Dalfó E; Avila J
    Curr Alzheimer Res; 2005 Jan; 2(1):3-18. PubMed ID: 15977985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
    Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
    Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease.
    Jazvinšćak Jembrek M; Slade N; Hof PR; Šimić G
    Prog Neurobiol; 2018 Sep; 168():104-127. PubMed ID: 29733887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.
    Morton H; Kshirsagar S; Orlov E; Bunquin LE; Sawant N; Boleng L; George M; Basu T; Ramasubramanian B; Pradeepkiran JA; Kumar S; Vijayan M; Reddy AP; Reddy PH
    Free Radic Biol Med; 2021 Aug; 172():652-667. PubMed ID: 34246776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease.
    Standridge JB
    Curr Alzheimer Res; 2006 Apr; 3(2):95-108. PubMed ID: 16611010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β, tau, and the cholinergic system in Alzheimer's disease: seeking direction in a tangle of clues.
    Majdi A; Sadigh-Eteghad S; Rahigh Aghsan S; Farajdokht F; Vatandoust SM; Namvaran A; Mahmoudi J
    Rev Neurosci; 2020 May; 31(4):391-413. PubMed ID: 32017704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta aggregation implicates multiple pathways in Alzheimer's disease: Understanding the mechanisms.
    Iliyasu MO; Musa SA; Oladele SB; Iliya AI
    Front Neurosci; 2023; 17():1081938. PubMed ID: 37113145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.
    Tiwari SS; Mizuno K; Ghosh A; Aziz W; Troakes C; Daoud J; Golash V; Noble W; Hortobágyi T; Giese KP
    Brain; 2016 Oct; 139(Pt 10):2751-2765. PubMed ID: 27524794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin dysfunction and Tau pathology.
    El Khoury NB; Gratuze M; Papon MA; Bretteville A; Planel E
    Front Cell Neurosci; 2014; 8():22. PubMed ID: 24574966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes.
    Kurt MA; Davies DC; Kidd M; Duff K; Howlett DR
    Neurobiol Dis; 2003 Oct; 14(1):89-97. PubMed ID: 13678670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease.
    Bhatia V; Sharma S
    J Neurol Sci; 2021 Feb; 421():117253. PubMed ID: 33476985
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.